平成27年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査係
1 腸管出血性大腸菌の発生状況累計グラフ
(1)散発患者発生動向調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
O157VT2 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
5 |
2 |
7 |
19 |
O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
1 |
2 |
4 |
5 |
13 |
その他 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
5 |
5 |
6 |
累計 |
1 |
2 |
2 |
2 |
4 |
5 |
6 |
7 |
8 |
9 |
9 |
10 |
11 |
14 |
23 |
34 |
51 |
90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
4 |
3 |
0 |
0 |
2 |
6 |
6 |
2 |
1 |
1 |
0 |
0 |
2 |
0 |
0 |
1 |
0 |
0 |
O157VT1,2 |
8 |
6 |
13 |
10 |
9 |
4 |
1 |
4 |
2 |
3 |
1 |
1 |
2 |
0 |
0 |
0 |
1 |
1 |
その他 |
1 |
2 |
8 |
8 |
6 |
2 |
1 |
0 |
0 |
2 |
2 |
0 |
0 |
0 |
5 |
0 |
1 |
0 |
累計 |
110 |
121 |
142 |
160 |
177 |
189 |
197 |
203 |
206 |
212 |
215 |
216 |
220 |
220 |
225 |
226 |
228 |
229 |
(2)無症状病原体保有者調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
その他 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
累計 |
0 |
1 |
1 |
1 |
1 |
1 |
2 |
3 |
3 |
3 |
4 |
4 |
5 |
5 |
7 |
8 |
9 |
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
0 |
0 |
0 |
1 |
0 |
1 |
2 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
O157VT1,2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
その他 |
0 |
3 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
累計 |
12 |
16 |
16 |
17 |
17 |
18 |
21 |
22 |
23 |
24 |
27 |
27 |
27 |
28 |
30 |
31 |
31 |
31 |
2 サルモネラの発生状況累計グラフ
(1)散発患者発生動向調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
2 |
0 |
O7 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
その他 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
累計 |
0 |
0 |
1 |
1 |
1 |
2 |
3 |
5 |
6 |
6 |
6 |
8 |
9 |
11 |
12 |
14 |
16 |
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
0 |
1 |
2 |
1 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
O9 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
2 |
0 |
0 |
1 |
0 |
その他 |
7 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
累計 |
24 |
26 |
29 |
30 |
30 |
30 |
31 |
31 |
32 |
33 |
33 |
35 |
37 |
40 |
40 |
40 |
41 |
41 |
(2)無症状病原体保有者調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
0 |
1 |
0 |
3 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
4 |
1 |
2 |
0 |
0 |
O7 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
1 |
1 |
1 |
1 |
1 |
0 |
O9 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
1 |
その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
2 |
0 |
累計 |
1 |
2 |
2 |
5 |
5 |
5 |
7 |
8 |
9 |
11 |
14 |
15 |
17 |
23 |
25 |
29 |
34 |
35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
0 |
1 |
0 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
O7 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
その他 |
1 |
2 |
1 |
0 |
1 |
0 |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
累計 |
37 |
41 |
43 |
43 |
44 |
44 |
50 |
52 |
52 |
54 |
54 |
55 |
56 |
56 |
57 |
58 |
59 |
59 |
※サルモネラ 無症状病原体保有者調査につきまして、平成28年3月9日に再確定致しました。
|